Specialties

Revised McDonald criteria allow earlier and more precise MS diagnosis

Presented By

Prof. Xavier Montalban, Vall d'Hebron University Hospital, Spain

Conference

ECTRIMS 2024

Type

Peer-reviewed article

18 November 2024 12:52

Approaches to RIS and MS converge

Presented By

Prof. Christine Lebrun-Frénay, Centre Hospitalier Universitaire de Nice, France

Conference

ECTRIMS 2024

Type

Peer-reviewed article

18 November 2024 12:50

AI versus clinicians: who diagnoses MS faster and better?

Presented By

Ms Mahi Patel, UT Southwestern, TX, USA

Conference

ECTRIMS 2024

Type

Peer-reviewed article

18 November 2024 12:47

Blood markers predict MS progression

Presented By

Dr Ahmed Abdelhak, University of California San Francisco, CA, USA

Conference

ECTRIMS 2024

Type

Peer-reviewed article

18 November 2024 12:46

Gut microbiota modulate inflammation and cortical damage

Presented By

Dr Federico Montini, Brigham and Women's Hospital, MA, USA

Conference

ECTRIMS 2024

Type

Peer-reviewed article

18 November 2024 12:43

Risk factors and importance of persistent PIRA

Presented By

Dr Chao Zhu, Monash University, Australia

Conference

ECTRIMS 2024

Type

Peer-reviewed article

18 November 2024 12:39

Vitamin D supplementation in progressive MS should be medically supervised

Presented By

Dr Michaela Haindl, Medical University of Graz, Austria

Conference

ECTRIMS 2024

Type

Peer-reviewed article

18 November 2024 12:38

Encouraging real-world results of AHSCT to treat aggressive MS

Presented By

Prof. Paolo Muraro, London Bridge Hospital, UK

Conference

ECTRIMS 2024

Type

Peer-reviewed article

18 November 2024 12:35

CAR T-cell therapy in MS: in its infancy but highly anticipated

Presented By

Prof. Frauke Zipp, Johannes Gutenberg University Mainz, Germany

Conference

ECTRIMS 2024

Type

Peer-reviewed article

18 November 2024 12:33

B cell-tailored dosing of ocrelizumab shows good results

Presented By

Ms Laura Hogenboom, Amsterdam University Medical Center, the Netherlands

Trial

BLOOMS

Conference

ECTRIMS 2024

Type

Peer-reviewed article

18 November 2024 12:28

Risk associated with discontinuing therapy depends on specific drug

Conference

ECTRIMS 2024

Type

Peer-reviewed article

18 November 2024 12:26

First-line moderate-efficacy DMTs show similar efficacy

Presented By

Dr Clara López-Caneda, Hospital Alvaro Cunqueiro, Spain

Conference

ECTRIMS 2024

Type

Peer-reviewed article

18 November 2024 12:23

Tolebrutinib slows disability worsening in relapsing MS

Presented By

Dr Jiwon Oh, St. Michael's Hospital, Canada

Trial

Phase 3, GEMINI 1, GEMINI 2

Conference

ECTRIMS 2024

Type

Peer-reviewed article

18 November 2024 12:21

Frexalimab shows favourable safety and efficacy in OLE

Presented By

Prof. Gavin Giovannoni, Queen Mary University of London, UK

Trial

Phase 2

Conference

ECTRIMS 2024

Type

Peer-reviewed article

18 November 2024 12:17

Good safety of ozanimod over up to 8 years of treatment

Presented By

Prof. Krzysztof Selmaj, University of Warmia and Mazury, Poland

Trial

DAYBREAK

Conference

ECTRIMS 2024

Type

Peer-reviewed article

18 November 2024 12:16

Tolebrutinib slows disability in non-relapsing SPMS

Presented By

Prof. Robert Fox, Cleveland Clinic, OH, USA

Trial

Phase 3, HERCULES

Conference

ECTRIMS 2024

Type

Peer-reviewed article

18 November 2024 12:13

High-dose simvastatin does not slow disability progression in SPMS

Presented By

Dr Jeremy Chataway, University College London, UK

Trial

Phase 3, MS-STAT2

Conference

ECTRIMS 2024

Type

Peer-reviewed article

18 November 2024 12:11

Transfer of ocrelizumab into breastmilk is negligible

Presented By

Dr Riley Bove, University of California San Francisco, CA, USA

Trial

Phase 4, SOPRANINO

Conference

ECTRIMS 2024

Type

Peer-reviewed article

18 November 2024 12:08

High genetic burden for depression associated with MS disease activity

Presented By

Dr Kaarina Kowalec, University of Manitoba, Canada

Conference

ECTRIMS 2024

Type

Peer-reviewed article

18 November 2024 12:06

More comorbidity is associated with worse clinical outcomes in MS

Presented By

Dr Amber Salter, UT Southwestern, TX, USA

Conference

ECTRIMS 2024

Type

Peer-reviewed article

18 November 2024 12:05

STEEER-AF: Shockingly low adherence to ESC atrial fibrillation guidelines

Presented By

Prof. Dipak Kotecha, University of Birmingham, UK

Trial

STEEER-AF

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 11:10

Vagal nerve stimulation for the reduction of cognitive impairment in Alzheimer’s disease

Presented By

Dr Adam Broncel, Neuromedical, Poland

Conference

EAN 2024

Type

News article

25 July 2024 11:07

Under investigation: Opioid use and the risk for dementia

Presented By

Dr Nelsan Pourhadi, Copenhagen University Hospital Rigshospitalet, Denmark

Conference

EAN 2024

Type

News article

25 July 2024 10:45

High risk for recurrent vascular events in young stroke patients

Presented By

Dr Jenna Broman, University of Helsinki, Finland

Conference

EAN 2024

Type

News article

25 July 2024 10:28

Anticoagulation or antiplatelet as secondary prevention for cancer-related strokes?

Presented By

Dr Moritz Kielkopf, University of Bern, Switzerland

Conference

EAN 2024

Type

News article

25 July 2024 10:26

Treatment escalation and de-escalation in late-onset MS

Presented By

Prof. Fredrik Piehl, Karolinska University Hospital, Sweden

Conference

EAN 2024

Type

News article

25 July 2024 10:22

How different are late onset and adult onset MS really?

Presented By

Dr Celine Louapre, Sorbonne University, France

Conference

EAN 2024

Type

News article

25 July 2024 10:17

Intensive BP intervention reduces risk of dementia 

Presented By

Dr Jiang He, Tulane University, USA

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 14:01

Breakthrough in Predicting MS Progression Through Genetic Testing

Expert

Prof. Sergio Baranzini, University of California San Francisco, CA, USA

4 December 2023 14:52

Retinal OCT markers hold promise for early MS diagnosis

Conference

MSMilan 2023

Type

Peer-reviewed article

4 December 2023 11:13

Early intensive treatment enhances long-term clinical outcomes

Presented By

Dr Pietro Iaffaldano, University of Bari, Italy

Conference

MSMilan 2023

Type

Peer-reviewed article

4 December 2023 11:12

χ-separation can assess the effects of tissue destruction in early MS lesions

Presented By

Dr Jannis Müller, University of Basel, Switzerland

Conference

MSMilan 2023

Type

Peer-reviewed article

4 December 2023 11:12

Anti-CD40L antibody safe and effective in a phase 2 study

Trial

Phase 2

Conference

MSMilan 2023

Type

Peer-reviewed article

4 December 2023 11:11

High sGFAP levels are associated with disease progression, independent of NfL or relapse activity

Presented By

Dr Pascal Benkert, University Hospital Basel, Switzerland

Conference

MSMilan 2023

Type

Peer-reviewed article

4 December 2023 11:11

Oral glycolipid shows promise in the treatment of MS, especially SPMS

Presented By

Dr Tomoko Okamoto, National Center Hospital, Tokyo, Japan

Trial

Phase 2

Conference

MSMilan 2023

Type

Peer-reviewed article

4 December 2023 11:10

Prioritising high efficacy therapies in children with MS

Presented By

Dr Nail Benallegue, Nantes University, France

Conference

MSMilan 2023

Type

Peer-reviewed article

4 December 2023 11:10

New insights into the contribution of EBV to MS pathogenesis

Presented By

Prof. Thomas Berger, Medical University of Vienna, Austria

Conference

MSMilan 2023

Type

Peer-reviewed article

4 December 2023 11:10

Early initiation of highly active treatment associated with a lower risk of SPMS

Presented By

Dr Christine Lebrun-Frenay, CHU de Nice, France

Trial

SPAM

Conference

MSMilan 2023

Type

Peer-reviewed article

4 December 2023 11:10

Broad rim lesions correlate with a rapidly progressive MS phenotype

Presented By

Dr Jussi Lehto, University of Turku, Finland

Conference

MSMilan 2023

Type

Peer-reviewed article

4 December 2023 11:10

Progressive brain tissue loss precedes the onset of clinical MS by years

Presented By

Dr Christina Azevedo, University of Southern California, CA, USA

Conference

MSMilan 2023

Type

Peer-reviewed article

4 December 2023 11:09

COVID-19 infection associated with higher MS relapse rate

Presented By

Mr David Levitz, Monash University, Australia

Conference

MSMilan 2023

Type

Peer-reviewed article

4 December 2023 11:09

Rate of grey matter brain atrophy accelerates after menopause

Presented By

Dr Alyssa Nylander, University of California, CA, USA

Trial

EPIC

Conference

MSMilan 2023

Type

Peer-reviewed article

4 December 2023 11:09

Omega-3 polyunsaturated fatty acids associated with lower risk of MS activity

Presented By

Dr Vinicius Schoeps, University of California, CA, USA

Conference

MSMilan 2023

Type

Peer-reviewed article

4 December 2023 11:09

Ocrelizumab more effective than interferon/glatiramer acetate in older MS patients

Presented By

Dr Yi Chao Foong, Monash University, Australia

Conference

MSMilan 2023

Type

Peer-reviewed article

4 December 2023 11:09

Smouldering inflammation detectable even in the earliest stages of MS

Presented By

Dr Markus Matilainen, University of Turku, Finland

Conference

MSMilan 2023

Type

Peer-reviewed article

4 December 2023 11:09

Fenebrutinib shows rapid reduction of new Gd+ T1 lesions

Presented By

Prof. Amit Bar-Or, University of Pennsylvania, PA, USA

Trial

Phase 2, FENopta

Conference

MSMilan 2023

Type

Peer-reviewed article

4 December 2023 11:09

Sickness absence rate increases years before clinical onset of MS

Presented By

Dr Ali Manouchehrinia, Karolinska University, Sweden

Conference

MSMilan 2023

Type

Peer-reviewed article

4 December 2023 11:08

Understanding what an MS cure means and what it takes

Presented By

Prof. Stephen Hauser, University of California, CA, USA

Conference

MSMilan 2023

Type

Peer-reviewed article

4 December 2023 11:08

Telerehabilitation effective in improving MS symptoms in patients with moderate disability

Presented By

Dr Maria Petracca, Sapienza University of Rome, Italy

Conference

MSMilan 2023

Type

Peer-reviewed article

4 December 2023 11:08

Challenges of de-escalation versus discontinuation of highly effective DMTs in older MS patients

Presented By

Prof. Vincent Van Pesch, UCLouvain, Belgium

Conference

MSMilan 2023

Type

Peer-reviewed article

4 December 2023 11:08

Real-world data supports ocrelizumab prior to conception

Presented By

Dr Wei Yeh, Alfred Health and Monash University, Australia

Conference

MSMilan 2023

Type

Peer-reviewed article

4 December 2023 11:07

Nightmares during childhood linked to cognitive decline later in life

Presented By

Dr Abidemi Otaiku, University of Birmingham, UK

Conference

EAN 2023

Type

Peer-reviewed article

7 September 2023 11:55

Which patients can initially be treated with platform DMT?

Presented By

Dr Ilaria Addazio, University of Florence, Italy

Conference

EAN 2023

Type

Peer-reviewed article

7 September 2023 11:44

Retinal layer thickness predicts disability accumulation in early RMS

Presented By

Prof. Gabriel Bsteh, Medical University of Vienna, Austria

Conference

EAN 2023

Type

Peer-reviewed article

7 September 2023 11:38

Withdrawing DMF in early pregnancy does not increase relapse risk in pregnant patients with MS

Presented By

Prof. Doriana Landi, University of Rome Tor Vergata, Italy

Conference

EAN 2023

Type

Peer-reviewed article

7 September 2023 11:12

Immunosenescence and MS: relevance to immunopathogenesis and treatment

Presented By

Prof. Monika Adamczyk-Sowa, Medical University of Silesia, Poland

Conference

EAN 2023

Type

Peer-reviewed article

7 September 2023 11:04

GLP-1 agonists induce weight loss and alleviate headache in idiopathic intracranial hypertension

Presented By

Dr Nik Krajnc, Medical University of Vienna, Austria

Conference

EAN 2023

Type

Peer-reviewed article

7 September 2023 11:00

80% of patients reverse from chronic to episodic migraine on anti-CGRP antibodies

Presented By

Dr Gabriella Egeo, IRCCS San Raffaele, Italy

Conference

EAN 2023

Type

Peer-reviewed article

7 September 2023 10:52

Towards cell biology of Alzheimer’s disease

Presented By

Prof. Thomas C. Südhof, Stanford Medicine, CA, USA

Conference

EAN 2023

Type

Peer-reviewed article

7 September 2023 10:35

Intensive BP reduction associated with smaller haematoma

Presented By

Prof. Qi Li, Chongqing Medical University, China

Trial

Phase 3, ATACH-2

Conference

EAN 2023

Type

Peer-reviewed article

7 September 2023 10:26

Contribution of genomics and genetics to personalised medicine

Presented By

Prof. Nicholas Wood, University College London, UK

Conference

EAN 2023

Type

Peer-reviewed article

7 September 2023 09:56

How big data can boost care for neurodegenerative disorders

Presented By

Prof. Gunhild Waldemar, University of Copenhagen, Denmark

Conference

EAN 2023

Type

Peer-reviewed article

7 September 2023 09:46

Novel backpack delivery system treats MS via innate immune cells

Expert

Prof. Samir Mitragotri, Harvard University, MA, USA

4 September 2023 15:08

Alzheimer’s disease and dementia: the road towards proactive and preventive care

Expert

Dr John Showalter, Linus Health, Boston, MA, USA

21 August 2023 14:51

Frequent co-existence of atrial fibrillation and obstructive sleep apnoea in stroke patients

Presented By

Dr Maria Rita Lo Monaco, Catholic University of the Sacred Heart, Italy

Conference

HFA 2023

Type

Peer-reviewed article

8 August 2023 16:27

Harnessing the microbiome as a possible stroke treatment

Presented By

Prof. Louise McCullough, University of Texas Health Science Center, TX, USA

Conference

AAN 2023

Type

Peer-reviewed article

26 June 2023 21:00

Patients with a large core infarct benefit from thrombectomy

Presented By

Dr Amrou Sarraj, UH Cleveland Medical Center, OH, USA

Trial

Phase 3, SELECT2

Conference

AAN 2023

Type

Peer-reviewed article

26 June 2023 20:57

Transcriptome data predicts long-term outcomes in untreated PPMS patients

Trial

ORATORIO

Conference

AAN 2023

Type

Peer-reviewed article

26 June 2023 20:42

Teriflunomide prevents conversion to MS in patients with RIS

Presented By

Prof. Christine Lebrun-Frenay, Centre Hospitalier Universitaire de Nice, France

Trial

Phase 3, TERIS

Conference

AAN 2023

Type

Peer-reviewed article

26 June 2023 20:39

Positive 4-year efficacy and safety data of ocrelizumab in early MS

Trial

Phase 3, ENSEMBLE

Conference

AAN 2023

Type

Peer-reviewed article

26 June 2023 20:36

Gold nanocrystals may be effective as adjunctive MS therapy

Presented By

Prof. Michael Barnett, University of Sydney, Australia

Trial

Phase 2, VISIONARY-MS

Conference

AAN 2023

Type

Peer-reviewed article

26 June 2023 20:33

Stem cell therapy fails primary endpoint but improves walking in more advanced progressive MS

Trial

Phase 2

Conference

AAN 2023

Type

Peer-reviewed article

26 June 2023 20:30

Ravulizumab effective in AQP4+ NMOSD

Presented By

Dr Sean Pittock, Mayo Clinic, NY, USA

Trial

Phase 3, CHAMPION-NMOSD

Conference

AAN 2023

Type

Peer-reviewed article

26 June 2023 20:28

Lecture on migraine: from the prodromal phase to future paradigm shifts

Presented By

Prof. Peter Goadsby, King's College London, UK

Conference

AAN 2023

Type

Peer-reviewed article

26 June 2023 20:24

Zavegepant nasal spray exhibits good efficacy and safety in acute migraine

Presented By

Prof. Richard Lipton, Albert Einstein College of Medicine, NY, USA

Trial

Phase 3

Conference

AAN 2023

Type

Peer-reviewed article

26 June 2023 20:18

Atogepant helps prevent treatment-resistant episodic migraine

Trial

ELEVATE

Conference

AAN 2023

Type

Peer-reviewed article

26 June 2023 20:13

Simultaneous head-to-head comparison of 25 migraine medications

Conference

AAN 2023

Type

Peer-reviewed article

26 June 2023 20:10

A vaccine as a potentially safe and effective immunotherapy against CGRP

Presented By

Dr Jean-Cosme Dodart, Vaxxinity Inc, FL, USA

Trial

Phase 1, UB-313

Conference

AAN 2023

Type

Peer-reviewed article

26 June 2023 20:04

Lecanemab may slow decline of cognition and function in Alzheimer’s Disease

Presented By

Prof. Christopher van Dyck, Yale School of Medicine, CT, USA

Trial

Phase 3, CLARITY AD

Conference

AAN 2023

Type

Peer-reviewed article

26 June 2023 19:44

Donanemab shows rapid and deep plaque clearance in early Alzheimer’s Disease

Presented By

Prof. Stephen Salloway, Warren Alpert Medical School of Brown University, RI, USA

Trial

Phase 3, TRAILBLAZER-ALZ 4

Conference

AAN 2023

Type

Peer-reviewed article

26 June 2023 19:38

Key correlates of incident dementia identified in the MESA study

Presented By

Dr Mohammad Ostovaneh, Johns Hopkins Hospital, MD, USA

Trial

MESA

Conference

ACC 2023

Type

Peer-reviewed article

7 June 2023 09:03

Looking Forward to 2023: Anticipated Medical Innovations

25 January 2023 02:35

Patients with migraines smoke less, drink less, and use fewer illicit drugs than general population

Presented By

Dr Thomas van den Hoek, Leiden University Medical Center, the Netherlands

Conference

EHC 2022

Type

News article

5 January 2023 11:43

Large gaps worldwide in prophylactic treatment of migraine

Trial

CaMEO-I

Conference

EHC 2022

Type

News article

5 January 2023 11:40

Atogepant for the preventive treatment of chronic migraine

Trial

Phase 3, PROGRESS

Conference

EHC 2022

Type

News article

5 January 2023 11:36

EHF consensus on effective migraine treatment and triptan failure

Presented By

Prof. Uwe Reuter, Charité University Hospital of Berlin, Germany

Conference

EHC 2022

Type

News article

5 January 2023 11:31

Sustained long-term effect of occipital nerve stimulation in MICCH

Presented By

Dr Roemer Brandt, Leiden University Medical Centre, Netherlands

Trial

ICON

Conference

EHC 2022

Type

News article

5 January 2023 11:28

Onabotulinumtoxin A effective in older patients with chronic migraine

Presented By

Dr Raffaele Ornello , University of L’Aquila, Italy

Conference

EHC 2022

Type

News article

5 January 2023 11:23

Zavegepant nasal spray effective for the acute treatment of migraine

Presented By

Dr Robert Croop

Trial

Phase 3

Conference

EHC 2022

Type

News article

5 January 2023 11:15

What to do when conventional treatment of headache fails in children

Presented By

Prof. Ishaq Abu-Arafeh, Royal Hospital for Children, Glasgow, UK

Conference

EHC 2022

Type

News article

5 January 2023 11:12

IHS President: “It is time for operationalisation of ICHD”

Presented By

Prof. Cristina Tassorelli , University of Pavia, Italy

Conference

EHC 2022

Type

News article

5 January 2023 10:57

Persistent headache after stroke: not rare and often overlooked

Presented By

Prof. Elena Lebedeva, Ural State Medical University, Russia

Conference

EHC 2022

Type

News article

5 January 2023 10:25

Additional effects of gepants on top of erenumab

Presented By

Dr Tessa de Vries, Erasmus Medical Center, the Netherlands

Conference

EHC 2022

Type

News article

5 January 2023 10:05

Re-myelination strategies in MS still pose many unanswered questions

Presented By

Prof. Catherine Lubetzki, Sorbonne University, France

Conference

ECTRIMS 2022

Type

Peer-reviewed article

20 December 2022 12:01

MS associated with a broader Epstein-Barr virus specific T-cell receptor repertoire

Presented By

Dr Tilman Schneider-Hohendorf, University of Muenster, Germany

Conference

ECTRIMS 2022

Type

Peer-reviewed article

20 December 2022 11:58

Cognitive rehab and mindfulness reduce cognitive complaints in MS

Presented By

Dr Ilse Nauta, Vrije Universiteit Amsterdam, the Netherlands

Trial

REMIND-MS

Conference

ECTRIMS 2022

Type

Peer-reviewed article

20 December 2022 11:56

COVID-19 and MS: lessons learned thus far

Presented By

Prof. Céline Louapre, Sorbonne University, France

Trial

COVISEP

Conference

ECTRIMS 2022

Type

Peer-reviewed article

20 December 2022 11:52

Ocrelizumab and fingolimod increase the risk of COVID-19 and of worse outcomes

Presented By

Dr Nikos Evangelou, Nottingham University Hospital, UK

Conference

ECTRIMS 2022

Type

Peer-reviewed article

20 December 2022 11:46

Humoral and cellular immune responses after SARS-CoV-2 vaccination

Presented By

Dr Monika Rabenstein, Karolinska Institute, Sweden

Conference

ECTRIMS 2022

Type

Peer-reviewed article

20 December 2022 11:42

Pregnancy and infant outcomes in women receiving ocrelizumab

Presented By

Prof. Celia Oreja-Guevara, University Hospital San Carlos, Spain

Conference

ECTRIMS 2022

Type

Peer-reviewed article

20 December 2022 10:29